Family Planning & Abortion Clinics in the US: Market Size, Businesses & Forecast 2026

The Family Planning & Abortion Clinics industry in the US consists of outpatient medical establishments providing contraceptive services, reproductive health counseling, STI screening, and pregnancy termination. The industry's geographic footprint and delivery models have shifted significantly following recent federal judicial changes, leading to a decline in brick-and-mortar clinics in restricted states alongside an expansion of virtual or telehealth-based providers. According to the Planned Parenthood Federation of America (PPFA) 2023-2024 Annual Report, their nationwide affiliates served 2.08 million patients and performed 402,200 abortions during that fiscal period, reflecting the ongoin

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Family Planning & Abortion Clinics in the US industry cover?

This industry comprises outpatient medical facilities with dedicated clinical staff primarily engaged in offering reproductive health and family planning services. The service envelope encompasses prescription and over-the-counter contraception management, pregnancy testing, prenatal and genetic counseling, voluntary sterilization procedures, and both medical and surgical pregnancy terminations. Additionally, many providers incorporate comprehensive screening and treatment for sexually transmitted infections (STIs) as part of their preventive health protocols.

• •Classified under the official North American Industry Classification System as NAICS code 621410 (Family Planning Centers).
• •Includes specialized abortion clinics, birth control centers, fertility consultancies, and pregnancy counseling operations.
• •Excludes general inpatient hospital services and independent offices of private physicians not explicitly focused on family planning.

Who operates in the industry and how is it structured?

The domestic market is heavily characterized by a mixture of non-profit federations, independent regional community clinics, and expanding digital-only telehealth networks. Non-profit organizations dominate the visible market share, relying on a combination of patient service revenues, government grants, and private philanthropic contributions. Due to changing legal environments across various states, the physical footprint of operators has contracted in certain regions while expanding through digital delivery infrastructure elsewhere.

• •The Guttmacher Institute reported that 753 brick-and-mortar clinics provided abortion services in the US at the end of 2025.
• •The total number of physical clinics represents a 2% decline from 765 clinics in March 2024 and a 7% drop from 807 clinics in 2020.
• •As of late 2025, there were zero operational brick-and-mortar abortion clinics in the 13 US states enforcing total abortion bans.

What drives demand in the industry?

The utilization of family planning services is fundamentally driven by demographic trends, public health guidelines, insurance coverage boundaries, and socio-economic variables. Access to subsidized care through federal programs significantly alters demand dynamics among lower-income brackets, while broader public awareness and regulatory approvals of over-the-counter products expand consumer options. Furthermore, geographic location and state-level protections dictate the physical or virtual channels patients navigate to obtain clinical care.

• •A CDC National Survey of Family Growth data brief for 2022-2023 noted that roughly one in three US females (ages 15-49) received a family planning service in the preceding 12 months.
• •The same CDC study showed service utilization increased with education, with 39.0% of women holding a bachelor's degree or higher accessing care versus 31.7% with a high school education or less.
• •Interstate patient travel grew drastically post-2022, peaking in 2023 when over 169,000 patients crossed state lines for abortion care before easing slightly to 142,000 in 2025.

Who are the notable companies in the industry?

The industry is highly fragmented at the corporate level, as no single publicly traded, investor-owned entity controls a majority stake in clinical service delivery. Instead, the landscape features multi-state non-profit networks, localized independent health centers, and emerging specialized digital health platforms. Prominent organizations establish competitive footprints through extensive physical infrastructure, comprehensive virtual healthcare apps, or strong philanthropic backing.

• •Planned Parenthood Federation of America (PPFA) operates as the largest non-profit provider network, delivering 2.2 million birth control services and 5.1 million STI tests in its 2023-2024 report.
• •FemiLife and Wisp, Inc. operate as major modern telehealth providers utilizing remote clinicians to prescribe and mail reproductive medications.
• •Hey Jane and Choix represent notable specialized virtual clinics focusing on digital reproductive care, expanding their presence via state shield laws.
• •Independent providers, such as Whole Woman's Health and Hope Clinic for Women, manage physical multi-state or regional brick-and-mortar operational hubs.

What are the recent trends and outlook?

The industry's near-term outlook is shaped by an aggressive transition toward remote or virtual clinical care and medication-based protocols. Telehealth infrastructure has dramatically altered the cost and delivery dynamics of family planning, mitigating some of the access hurdles caused by local brick-and-mortar closures. This ongoing structural shift is expected to sustain total national service volumes despite intense regional disruptions.

• •Online-only or virtual clinics accounted for 24% of all clinician-provided abortions in the US in 2025, up from 20% in 2024 and 12% in 2023.
• •Medication-based methods accounted for 65% of all clinician-provided abortions nationwide according to 2023 figures, rising from 53% in 2020.
• •The FDA approval and subsequent 2024 retail launch of Opill as the first daily over-the-counter birth control pill shifted consumer access models.

How is the industry regulated?

Operators face an exceptionally complex and fragmented regulatory framework that varies completely by state jurisdiction. Compliance protocols dictate licensing rules, mandatory waiting periods, telemedicine parameters, and criminal or civil liability boundaries for medical personnel. At the federal level, operators navigate strict funding criteria regarding the distribution of public healthcare grants and insurance reimbursements.

• •The Small Business Administration (SBA) designates a small business size standard threshold of $19.0 million in annual revenue for NAICS 621410.
• •State-level 'shield laws' enacted in jurisdictions like New York, Washington, and Maine protect clinicians prescribing via telehealth to out-of-state patients.
• •The federal Title X Family Planning Program dictates strict administrative compliance for clinics receiving federal grants for low-income preventive care.

Government, statistical and trade sources used for this Claight analysis.

• US Census Bureau North American Industry Classification System 2022 ·
• US Small Business Administration Table of Size Standards 2023 ·
• CDC National Center for Health Statistics Data Brief No. 520 (Published 2025) ·
• Guttmacher Institute Monthly Abortion Provision Study Reports (2024-2025 Releases) ·
• Planned Parenthood Federation of America 2023-2024 Annual Report